Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.

Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- Check7 days agoChange DetectedThe study record NCT03873818 on ClinicalTrials.gov was updated with a new last update date (2025-04-27) and current enrollment status.SummaryDifference0.4%

- Check14 days agoNo Change Detected
- Check35 days agoChange DetectedUpdate includes a critical operating status notice and a new software version (v3.2.0), indicating updated deployment status and the presence of temporary funding-related notices; the previous version tag (v3.1.0) was removed.SummaryDifference3%

- Check43 days agoChange DetectedSignificant expansion of immune-related terminology and an explicit version upgrade to v3.1.0. Older version v3.0.2 is removed.SummaryDifference0.9%

- Check57 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); the 'Back to Top' element was removed as a minor UI change.SummaryDifference0.2%

- Check64 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.2%

- Check71 days agoChange DetectedThe web page has been updated to include a new facility name and location, along with additional medical topics related to brain tumors and skin diseases. Notably, the previous version's references to certain antineoplastic agents and specific melanoma topics have been removed.SummaryDifference3%

Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.